PLRX
PLIANT THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.11
−1.77%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.37
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.36
- EPS estimate
- -$0.34
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.1%
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.34 | -$0.36 | Miss -5.33% | — |
| May 11, 2026 | -$0.36 | -$0.32 | Beat 11.11% | — |
| Mar 11, 2026 | -$0.38 | -$0.35 | Beat 7.56% | — |
| Nov 6, 2025 | -$0.53 | -$0.43 | Beat 18.87% | — |
| Aug 7, 2025 | -$0.62 | -$0.71 | Miss -14.52% | — |
| May 8, 2025 | -$0.78 | -$0.92 | Miss -17.95% | — |
| Mar 3, 2025 | -$0.99 | -$0.82 | Beat 17.17% | — |
| Nov 7, 2024 | -$0.99 | -$0.95 | Beat 4.04% | — |
| Feb 27, 2024 | -$0.81 | -$0.69 | Beat 14.81% | $4.8M |
| Nov 9, 2023 | -$0.78 | -$0.70 | Beat 10.26% | — |
| Mar 9, 2023 | -$0.70 | -$0.72 | Miss -2.86% | $2.0M |
| Feb 28, 2022 | -$0.76 | -$0.68 | Beat 10.53% | $2.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026